VEA
TYRA icon

Virtus ETF Advisers’s Tyra Biosciences TYRA Stock Holding History

Virtus ETF Advisers’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,686
Closed -$65.1K – 782
2024
Q4 		$65.1K Buy
4,686
+44
+0.9% +$799 0.03% 421
2024
Q3 		$109K Buy
4,642
+82
+2% +$1.72K 0.05% 362
2024
Q2 		$72.9K Buy
+4,560
New +$78.5K 0.04% 426

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Virtus ETF Advisers's TYRA Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Tyra Biosciences (TYRA) in Q1 2025, closing a stake of 4,686 shares — an estimated $65.1K sold.

Virtus ETF Advisers first reported a position in TYRA in Q2 2024 and held it in 3 quarters. The position peaked at $109K in Q3 2024. 117 funds tracked by Wall St. Rank hold TYRA as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Tyra Biosciences position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 4,686 Tyra Biosciences shares in Q1 2025, an estimated $65.1K.
  • Virtus ETF Advisers first reported a position in Tyra Biosciences in Q2 2024 and held it in 3 quarters.
  • Virtus ETF Advisers's Tyra Biosciences position peaked at $109K in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.